CLINICAL_TRIALS
trial_result
· 2021-11-30
Clinical Trial Update: IIT Assessing OC-01Nasal Spray on Symptoms of DED Following CXL [Phase 2]
Summary
A Phase 2 clinical trial update evaluating OC-01 nasal spray for symptoms of Dry Eye Disease after corneal collagen crosslinking.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vance Thompson Vision - MT | Conditions: Dry Eye Disease | Phase 2 | Status: UNKNOWN